CAPR Has The Potential For Big Profits
Hello,
What is CAPR?
Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders.
News
Shares of Capricor Therapeutics Inc. (CAPR) are currently down despite the company announcing positive top-line results from a study of its lead candidate in the treatment of a muscle degeneration disorder. Clinical-stage biotechnology company Capricor Tuesday announced positive top-line 12-month results of the HOPE-2 clinical trial using CAP-1002 to treat patients in advanced stages of Duchenne muscular dystrophy (DMD).
DMD is a genetic disorder characterized by progressive weakness and chronic inflammation of the skeletal, heart, and respiratory muscles. Boys and young men typically lose their ability to walk in their teens and generally die of cardiac or respiratory complications in their 30s. The study data showed improvements in upper limb, cardiac, and respiratory function.
My Thoughts For You
Looking at the monthly time-frame you will see some wild price swings, I think we are due for another wild ride to the moon. Additionally, I would like to mention that this company is working on a vaccine for Covid-19.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
What is CAPR?
Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders.
News
Shares of Capricor Therapeutics Inc. (CAPR) are currently down despite the company announcing positive top-line results from a study of its lead candidate in the treatment of a muscle degeneration disorder. Clinical-stage biotechnology company Capricor Tuesday announced positive top-line 12-month results of the HOPE-2 clinical trial using CAP-1002 to treat patients in advanced stages of Duchenne muscular dystrophy (DMD).
DMD is a genetic disorder characterized by progressive weakness and chronic inflammation of the skeletal, heart, and respiratory muscles. Boys and young men typically lose their ability to walk in their teens and generally die of cardiac or respiratory complications in their 30s. The study data showed improvements in upper limb, cardiac, and respiratory function.
My Thoughts For You
Looking at the monthly time-frame you will see some wild price swings, I think we are due for another wild ride to the moon. Additionally, I would like to mention that this company is working on a vaccine for Covid-19.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.